Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency.
Acetates
/ metabolism
Algorithms
Animals
Brain
/ metabolism
Carbon Isotopes
Cerebral Cortex
/ metabolism
Disease Models, Animal
Electroencephalography
Evoked Potentials
Gamma Rhythm
Glucose
/ metabolism
Glutamic Acid
/ metabolism
Humans
Machine Learning
Mice
Neural Inhibition
Neurons
/ physiology
Pyruvate Dehydrogenase Complex Deficiency Disease
/ metabolism
Seizures
/ metabolism
Vibrissae
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
20 02 2019
20 02 2019
Historique:
received:
02
03
2017
revised:
25
09
2018
accepted:
31
01
2019
entrez:
22
2
2019
pubmed:
23
2
2019
medline:
23
2
2020
Statut:
ppublish
Résumé
Glucose is the ultimate substrate for most brain activities that use carbon, including synthesis of the neurotransmitters glutamate and γ-aminobutyric acid via mitochondrial tricarboxylic acid (TCA) cycle. Brain metabolism and neuronal excitability are thus interdependent. However, the principles that govern their relationship are not always intuitive because heritable defects of brain glucose metabolism are associated with the paradoxical coexistence, in the same individual, of episodic neuronal hyperexcitation (seizures) with reduced basal cerebral electrical activity. One such prototypic disorder is pyruvate dehydrogenase (PDH) deficiency (PDHD). PDH is central to metabolism because it steers most of the glucose-derived flux into the TCA cycle. To better understand the pathophysiology of PDHD, we generated mice with brain-specific reduced PDH activity that paralleled salient human disease features, including cerebral hypotrophy, decreased amplitude electroencephalogram (EEG), and epilepsy. The mice exhibited reductions in cerebral TCA cycle flux, glutamate content, spontaneous, and electrically evoked in vivo cortical field potentials and gamma EEG oscillation amplitude. Episodic decreases in gamma oscillations preceded most epileptiform discharges, facilitating their prediction. Fast-spiking neuron excitability was decreased in brain slices, contributing to in vivo action potential burst prolongation after whisker pad stimulation. These features were partially reversed after systemic administration of acetate, which augmented cerebral TCA cycle flux, glutamate-dependent synaptic transmission, inhibition and gamma oscillations, and reduced epileptiform discharge duration. Thus, our results suggest that dysfunctional excitability in PDHD is consequent to reduced oxidative flux, which leads to decreased neuronal activation and impaired inhibition, and can be mitigated by an alternative metabolic substrate.
Identifiants
pubmed: 30787166
pii: 11/480/eaan0457
doi: 10.1126/scitranslmed.aan0457
pmc: PMC6637765
mid: NIHMS1036050
pii:
doi:
Substances chimiques
Acetates
0
Carbon Isotopes
0
Glutamic Acid
3KX376GY7L
Carbon-13
FDJ0A8596D
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIBIB NIH HHS
ID : P41 EB015908
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS077015
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS102588
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK076174
Pays : United States
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
J Cereb Blood Flow Metab. 2013 Aug;33(8):1160-7
pubmed: 23652627
Nat Commun. 2014 Apr 29;5:3611
pubmed: 24781306
Nat Neurosci. 2015 Mar;18(3):351-9
pubmed: 25710837
Biophys J. 1991 Nov;60(5):1164-77
pubmed: 1760506
Am J Physiol Regul Integr Comp Physiol. 2004 Mar;286(3):R528-38
pubmed: 14630625
J Neurochem. 2015 Feb;132(3):301-12
pubmed: 25314677
NMR Biomed. 2012 Nov;25(11):1234-44
pubmed: 22419606
Nat Rev Neurosci. 2012 May 18;13(6):407-20
pubmed: 22595786
Annu Rev Neurosci. 2012;35:203-25
pubmed: 22443509
J Cereb Blood Flow Metab. 2001 Apr;21(4):404-12
pubmed: 11323526
Elife. 2015 Jun 23;4:e06513
pubmed: 26102526
Neurologist. 2008 Nov;14(6 Suppl 1):S2-S14
pubmed: 19225367
Pediatr Neurol. 1993 May-Jun;9(3):216-20
pubmed: 8352855
J Neurophysiol. 2001 Oct;86(4):2029-40
pubmed: 11600659
Nature. 1950 Sep 9;166(4219):439-40
pubmed: 14775707
Brain Res. 1992 Aug 14;588(1):49-57
pubmed: 1393571
Curr Opin Neurobiol. 2011 Apr;21(2):269-74
pubmed: 21353526
J Neurochem. 2013 Sep;126(5):579-90
pubmed: 23745684
J Neurosci. 1998 Aug 15;18(16):6395-410
pubmed: 9698331
Neural Comput. 2004 Aug;16(8):1661-87
pubmed: 15228749
J Neurosci. 1998 Jul 15;18(14):5225-33
pubmed: 9651205
J Biol Chem. 1988 May 25;263(15):6964-71
pubmed: 3284880
Neuroscience. 2007 Feb 23;144(4):1305-13
pubmed: 17197104
J Neurochem. 1964 Mar;11:165-85
pubmed: 14165154
Biochemistry. 1990 Jul 24;29(29):6756-61
pubmed: 1975750
Nat Neurosci. 2007 Apr;10(4):462-8
pubmed: 17334362
J Neurochem. 1974 May;22(5):709-15
pubmed: 4407094
Neuron. 2007 Jul 5;55(1):131-41
pubmed: 17610822
J Neurochem. 2007 Dec;103(5):2077-91
pubmed: 17854388
Neurochem Res. 2017 Mar;42(3):810-826
pubmed: 27933548
J Cereb Blood Flow Metab. 2014 Jan;34(1):153-60
pubmed: 24169853
Epilepsia. 2017 May;58(5):845-857
pubmed: 28294308
Dev Neurosci. 1998;20(4-5):310-20
pubmed: 9778567
Transgenic Res. 2008 Oct;17(5):919-28
pubmed: 18483774
J Neurosci. 2011 Jun 15;31(24):8699-705
pubmed: 21677152
J Neurosci. 1987 Oct;7(10):3306-16
pubmed: 2822865
Int J Alzheimers Dis. 2011;2011:347569
pubmed: 21629743
Brain. 2011 Jul;134(Pt 7):e180; author reply e181
pubmed: 21378098
PLoS One. 2016 Feb 24;11(2):e0150095
pubmed: 26910900
Front Cell Neurosci. 2018 Aug 31;12:274
pubmed: 30233320
Trends Neurosci. 2018 Jul;41(7):415-417
pubmed: 29739627
Mol Genet Metab. 2012 Jul;106(3):385-94
pubmed: 22896851
J Neurosci. 2011 Apr 20;31(16):6221-34
pubmed: 21508245
J Neurophysiol. 2008 Nov;100(5):2615-26
pubmed: 18784272
Biochem J. 1963 Sep;88:566-78
pubmed: 14071531
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):109-11
pubmed: 15608007
Am J Physiol Endocrinol Metab. 2016 Dec 1;311(6):E911-E921
pubmed: 27651111
Nature. 2014 Jan 2;505(7481):92-6
pubmed: 24256726
J Neurophysiol. 2007 Jan;97(1):647-58
pubmed: 17065248
J Cereb Blood Flow Metab. 2007 Dec;27(12):1895-907
pubmed: 17440492
J Neurosci. 2004 Dec 15;24(50):11273-9
pubmed: 15601933
Lancet. 1993 Jun 26;341(8861):1607-10
pubmed: 8099987
J Neurochem. 2015 Jan;132(1):99-109
pubmed: 25231025
J Physiol. 2014 Jul 1;592(13):2711-9
pubmed: 24756635
J Neurochem. 2009 May;109 Suppl 1:46-54
pubmed: 19393008
Biochem J. 2006 Aug 1;397(3):417-25
pubmed: 16606348
Neurochem Int. 2005 Jul;47(1-2):119-28
pubmed: 15888376
Methods Mol Biol. 2011;708:147-57
pubmed: 21207288
J Physiol. 1999 Jan 15;514 ( Pt 2):327-41
pubmed: 9852317
Neuron. 2010 Oct 6;68(1):99-112
pubmed: 20920794
Neuron. 2012 Apr 12;74(1):193-205
pubmed: 22500640
J Cereb Blood Flow Metab. 2014 Aug;34(8):1270-82
pubmed: 24896567
Neurochem Int. 2012 Dec;61(7):1036-43
pubmed: 22884585
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18638-43
pubmed: 16339306
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Mol Genet Metab. 2001 Nov;74(3):293-302
pubmed: 11708858
Elife. 2018 Jan 25;7:
pubmed: 29368690
NMR Biomed. 1999 Nov;12(7):451-62
pubmed: 10654292
J Neurosci Methods. 2012 Jan 15;203(1):50-5
pubmed: 21946227
Nature. 2009 Jun 4;459(7247):698-702
pubmed: 19396159
J Cereb Blood Flow Metab. 2010 Jun;30(6):1200-13
pubmed: 20125180
Acta Physiol Scand. 1974 Jun;91(2):154-64
pubmed: 4844242